Q2 2024 Conmed Corp Earnings Call Transcript
Key Points
- Conmed Corp (CNMD) achieved a record high quarterly sales result with total sales of $332 million, marking a year-over-year increase of 4.5% as reported and 5.2% in constant currency.
- The company's GAAP net income for the second quarter was $30 million, more than doubling from $13.7 million in the same quarter of 2023.
- Adjusted net income increased by 17.2% year-over-year, and adjusted diluted net earnings per share rose by 18.1%, indicating strong financial performance.
- General surgery revenue showed robust growth, increasing by 9.4% worldwide, with U.S. revenue up by 8.9% and international revenue by 10.5%.
- Conmed Corp (CNMD) improved its leverage ratio to 3.8 times, better than expected, and demonstrated strong cash flow from operations, which increased to $43.3 million from $26.7 million in the previous year.
- The orthopedic segment faced supply chain challenges, leading to a decline of 0.1% in worldwide sales, with U.S. sales down by 0.4%.
- Supply constraints in key implantables, particularly in sports medicine and foot and ankle businesses, have not been resolved as quickly as anticipated.
- The company had to lower its guidance for the remainder of the year due to ongoing supply chain issues, impacting its ability to fully capitalize on market opportunities.
- Conmed Corp (CNMD) experienced unexpected supplier closures, which disrupted production and contributed to inefficiencies.
- The company acknowledged that its margin expansion targets for 2024 and 2025 might be delayed due to current supply chain challenges.
Good day, and thank you for standing by. Welcome to CONMEDâs second quarter Fiscal 2024 Earnings conference call. At this time, all participants are in a listen-only mode. After the speakersâ presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that todayâs conference is being recorded.
Before the conference call begins, let me remind you that during the call, management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risks and uncertainties as those terms are defined under the federal securities laws. Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results.
The companyâs actual results may differ materially from its current expectations. Please refer to the risks and other uncertainties disclosed under the forward-looking information in todayâs press release as well as the companyâs SEC filings for more details on the risks and uncertainties that may
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
